Recent Advances in Anti Tubercular Drugs

Kadam, Manish S and Nagappa, Anantha Naik and Gnana Sam, Kishore (2010) Recent Advances in Anti Tubercular Drugs. Journal of Pharmaceutical Research, 9 (2).

[img] PDF
april_2010_pdf_01.pdf - Published Version
Restricted to Registered users only

Download (739kB) | Request a copy


Tuberculosis is a scourge for human race for millennia with huge morbidity and mortality. Among the main obstacles to the global control of the disease are the HIV epidemic that has dramatically increased the risk for developing active TB, the increasing emergence of multi-drug resistant TB (MDR-TB), Extensive drug resistant tuberculosis (XDR-TB) and the recalcitrance of persistent infections to treatment with conventional anti-TB drugs. Anti-tuberculosis drug resistance is a major public health problem that threatens the success of Directly Observed Treatment Short Course (DOTS), the WHO-recommended treatment strategy for detection and cure of TB, as well as global tuberculosis control. This has made the currently available anti tubercular drugs into less effective and futile tools to control tuberculosis. Not only to radically transform the fight against tuberculosis but also to shortening the current six to eight-month treatment to two months or less. This in turn will improve patient adherence, increase cure rates, and lessen the likelihood of patients developing drug resistance. New drugs are also needed to benefit the growing number of people around the globe who are co-infected with TB and HIV, as well as those who have been exposed to TB but are not yet ill with disease i.e. latent TB.

Item Type: Article
Uncontrolled Keywords: Tuberculosis; Anti-tuberculosis drug; Fluoroquinolones
Subjects: Pharmacy > MCOPS Manipal > Pharmacy Management
Pharmacy > MCOPS Manipal > Pharmacy Practice
Depositing User: KMC Manipal
Date Deposited: 24 Jan 2012 06:24
Last Modified: 24 Jan 2012 06:24

Actions (login required)

View Item View Item